Experiences in liver transplantation for hepatocellular carcinoma

Transplantation Proceedings

Volumn 36, Issue 1, 2004, Pages 195-198

  Stadlbauer, V ^a,b   Schaffellner, S ^a   Kniepeiss, D ^a   Jakoby, E ^a   Stauber, R ^a   Iberer, F ^a   Tscheliessnigg, K H ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TUMOR MARKER;

ACUTE GRAFT REJECTION; ADULT; AGED; ALLOGRAFT; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CAUSE OF DEATH; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; DRUG EXPOSURE; DRUG WITHDRAWAL; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LONG TERM EXPOSURE; MALE; PRIORITY JOURNAL; RADIOFREQUENCY; SCREENING; SURGICAL PATIENT; SURGICAL TECHNIQUE; SYMPTOM; VASCULAR DISEASE;

EID: 0842303309     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.11.009     Document Type: Conference Paper

References (26)

1. Akriviadis E.A., Llovet J.M., Efremidis S.C., et al. Hepatocellular carcinoma. Br J Surg. 85:1998;1319.
2. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 340:1999;745.
3. Okuda K., Ohtsuki T., Obata H., et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 56:1985;918.
4. Bismuth H., Majno P.E., Adam R. Liver transplantation for hepatocellular carcinoma. Sem Liver Dis. 19:1999;311.
5. Colleoni M., Audisio R.A., De Braud F., et al. Practical considerations in the treatment of hepatocellular carcinoma. Drugs. 55:1998;367.
6. Mor E., Kaspa R.T., Sheiner P., et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Int Med. 129:1998;643.
7. Llovet J.M., Bruix J., Gores G.J. Surgical resection versus transplantation for early hepatocellular carcinoma clues for the best strategy . Hepatology. 31:2000;1019.
8. Sarmiento J.M., Que F.G., Nagorney D.M. Surgical outcomes of isolated caudate lobe resection a single series of 19 patients . Surgery. 32:2002;697.
9. Sugioka A., Tsuzuki T., Kanai T. Postresection of patients with hepatocellular carcinoma. Surgery. 113:1993;612.
10. Nagasue N., Kohno H., Chang Y.C., et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg. 217:1993;375.
11. Livraghi T., Giorgio A., Marin G., et al. Hepatocellular carcinoma and cirrhosis in 746 patients long-term results of percutaneous ethanol injection . Radiology. 197:1995;101.
12. Yamamoto J., Okada S., Shimada K., et al. Treatment strategy for small hepatocellular carcinoma comparison of long-term results after percutaneous ethanol injection therapy and surgical resection . Hepatology. 24:2001;707.
13. Llovet J.M., Real M.I., Montana X., et al. Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma a randomised controlled trial . Lancet. 359:2002;1734.
14. Sangro B., Qian C., Schmitz V., et al. Gene therapy of hepatocellular carcinoma and gastrointestinal tumors. Ann N Y Acad Sci. 963:2002;6.
15. Iwatsuki S., Gordon R.D., Shaw B.W. Jr, et al. Role of liver transplantation in cancer therapy. Ann Surg. 202:1985;401.
16. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 334:1996;693.
17. Teefey S.A., Hildeboldt C.C., Dehdashti F., et al. Detection of primary hepatic malignancy in liver transplant candidates prospective comparison of CT, MR imaging, US, and PET . Radiology. 226:2003;533.
18. De Carlis L., Giacomoni A., Pirotta V., et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. Transpl Int. 16:2003;115.
19. Lerut J., Gertsch P., Blumgart L.H. "Piggy back" adult orthotopic liver transplantation. Helv Chir Act. 56:1989;527.
20. Venook A.P., Ferrell L.D., Roberts J.P., et al. Liver transplantation for hepatocellular carcinoma results with preoperative chemoembolization . Liver Transpl Surg. 1:1995;242.
21. Majno P.E., Adam R., Bismuth H., et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 226:1997;688.
22. Harnois D.M., Steers J., Andrews J.C., et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg. 5:1999;192.
23. Roayaie S., Frischer J.S., Emre S.H., et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg. 235:2002;533.
24. Vivarelli M., Bellusci R., Cucchetti A., et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation better patient selection or lower immunosuppression . Transplantation. 748:2002;1746.
25. Klintmalm G.B. Liver transplantation for hepatocellular carcinoma a registry report of the impact of tumor characteristics on outcome . Ann Surg. 228:1998;479.
26. Wiederrecht G.J., Sabers C.J., Brunn G.J., et al. Mechanism of action of rapamycin new insights into the regulation of G1-phase progression in eukaryotic cells . Prog Cell Cycle Res. 1:1995;53.